CareDx Reports Fourth Quarter and Full Year 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
CareDx (CDNA) Misses Q4 EPS by 6c
February 24, 2022 4:27 PM ESTCareDx (NASDAQ: CDNA) reported Q4 EPS of ($0.03), $0.06 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $79.2 million versus the consensus estimate of $78.09 million.
GUIDANCE:
CareDx sees FY2022 revenue of $330-350 million, versus the consensus of $343... More
